Comparsion Between Intravenous Infusion of Ketofol and Inhalational Anasthetics in Abdominal Cancer Surgeries for Post Operative Analgesia
1 other identifier
observational
80
0 countries
N/A
Brief Summary
( post operative pain between intravenous infusion ketofol and standard inhalational general anesthesia in abdominal cancer surgeries )
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Mar 2024
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 11, 2024
CompletedFirst Posted
Study publicly available on registry
February 20, 2024
CompletedStudy Start
First participant enrolled
March 1, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 1, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
May 1, 2025
CompletedFebruary 20, 2024
February 1, 2024
1 year
February 11, 2024
February 11, 2024
Conditions
Outcome Measures
Primary Outcomes (1)
post operative pain
pain according to VAS score
two hours
Study Arms (1)
The sample will be randomly assigned into one of two equal groups ((Group-I (n
Sample size calculation was carried out using G\*Power 3 software (Faul et al., 2007)1 calculated minimum sample of 80 patient candidate for cancer surgery will be needed. The sample will be randomly assigned into one of two equal groups ((Group-I (n=40): will receive standard general anesthesia as control, and Group III (n=40): will receive Ketofol in addition to the standard general anesthesia. The calculated sample will be needed to detect an effect size of 0.1 in the RM-ANOVA (within group-between groups and interaction) on repeated measurements (every 2-hours postoperatively) for the mean VAS score, with an error probability of 0.05 and 95% power.
Eligibility Criteria
Inclusion Criteria: * a. Inclusion criteria: 1. Age group 18 - 60 years old. 2. Both gender 3. ASA 1and 2 Exclusion Criteria: * a. Inclusion criteria: 1. Age group 18 - 60 years old. 2. Both gender 3. ASA 1and 2 b. Exclusion criteria: <!-- --> 1. Patient refusal, 2. History of cardiac or respiratory disease, psychological disorders, 3. High risk of regurgitation or aspiration based on a history of diabetes, hiatus hernia, gastroesophageal reflux, and obesity, 4. neck pathology, 5. Predicted difficult airway (history of difficult airway, mouth opening
You may qualify if:
- Age group 18 - 60 years old.
- Both gender
- ASA 1and 2
You may not qualify if:
- Age group 18 - 60 years old.
- Both gender
- <!-- -->
- Patient refusal,
- History of cardiac or respiratory disease, psychological disorders,
- High risk of regurgitation or aspiration based on a history of diabetes,
- hiatus hernia, gastroesophageal reflux, and obesity,
- neck pathology,
- Predicted difficult airway (history of difficult airway, mouth opening
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- doctor
Study Record Dates
First Submitted
February 11, 2024
First Posted
February 20, 2024
Study Start
March 1, 2024
Primary Completion
March 1, 2025
Study Completion
May 1, 2025
Last Updated
February 20, 2024
Record last verified: 2024-02